Skip to main content
. Author manuscript; available in PMC: 2018 Apr 15.
Published in final edited form as: Development. 2017 Sep 11;144(20):3808–3818. doi: 10.1242/dev.146902

Fig. 1. Efficient ubiquitous deletion of Taf10 in E9.5 R26Cre;Taf10 mutant embryos.

Fig. 1

(A-F) Whole-mount Xgal staining of R26CreERT2/R;Taf10flox/+ control at E9.5 (A) R26+/R;Taf10flox/flox control at E10.5 (C) and E11.5 (E), and R26CreERT2/R;Taf10flox/flox mutant at E9.5 (B), E10.5 (D) and E11.5 (F) after tamoxifen treatment at E7.5 (+tam). (G) Western blot analysis of E9.5 R26Cre;Taf10 whole embryos treated (+) or not (-) with tamoxifen at E7.5 with anti-TAF10 and anti-histone H3 antibodies. (H-I) Confocal z-stack images projection of E9.25 R26Cre;Taf10;Luvelu/+ untreated (H) or tamoxifzn-treated (I) embryos. Scale bars in A-F and H-I represent 500 µm, and 100 µm, respectively tam; tamoxifen. so; somites